TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT
TransCode Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 11.57M | 5.81M | 1.88M | 3.35M | 4.91M | 2.77M | 7.45M | 3.57M | 1.62M | 4.97M | 8.79M | 13.44M | 16.85M | 20.83M | 22.5M | 79.57K | 98.96K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.45K | 9.35K | 12.89K |
Other Long-Term Assets | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 247.65K | -0.00 | 235.82K | -0.00 | n/a | n/a | -9.45K | 881.1K | 373.63K |
Receivables | 322.44K | n/a | 11.95K | n/a | n/a | n/a | n/a | n/a | n/a | 360.23K | 487.88K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 554.33K | 182.06K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 681.18K | 828.22K | 1.25M | 532.46K | 1.48M | 1.14M | 1.08M | 1.32M | 2.16M | 1.5M | 2.11M | 329.27K | 1.68M | 1.84M | 2.65M | n/a | n/a |
Total Current Assets | 13.04M | 7.09M | 3.61M | 4.39M | 6.71M | 4.46M | 9.37M | 4.89M | 4.35M | 7.38M | 11.57M | 13.92M | 18.63M | 22.73M | 25.2M | 540.22K | 577.76K |
Property-Plant & Equipment | 38.13K | 89.31K | 211.66K | 326.31K | 464.59K | 602.4K | 742.57K | 876.75K | 996.23K | 208.58K | 209.87K | 234.67K | 215.32K | 206.27K | 155.61K | 91.59K | 74.05K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 149.99K | 201.16K | 323.52K | 438.17K | 576.45K | 714.26K | 854.43K | 988.61K | 1.24M | 208.58K | 445.69K | 234.67K | 215.32K | 206.27K | 155.61K | 982.05K | 460.57K |
Total Assets | 13.19M | 7.29M | 3.94M | 4.82M | 7.29M | 5.17M | 10.23M | 5.88M | 5.59M | 7.59M | 12.02M | 14.16M | 18.85M | 22.94M | 25.36M | 1.52M | 1.04M |
Account Payables | n/a | n/a | n/a | n/a | n/a | 2.33M | 4.86M | 3.04M | 5.06M | 4.35M | n/a | 1.7M | 1.75M | 2.02M | 1.98M | n/a | n/a |
Deferred Revenue | n/a | 25.41K | n/a | n/a | -1.86M | 27.06K | 54.31K | 81.75K | -5.06M | n/a | 23.54K | 23.54K | 23.54K | 30.53K | 220.07K | 251.81K | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | 309.06K | -2.33M | -4.86M | -2.65M | -5.06M | -4.35M | 3.61M | -1.7M | -1.75M | -2.02M | -1.98M | 281.08K | -35.52K |
Total Current Liabilities | 2.51M | 2.77M | 2.28M | 3.5M | 2.71M | 3.49M | 5.6M | 3.52M | 5.45M | 4.35M | 3.77M | 1.73M | 1.85M | 2.53M | 2.2M | 1.53M | 788.84K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.13M | 2.11M |
Other Long-Term Liabilities | 392K | 6.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.9M | 5.99M |
Total Long-Term Liabilities | 392K | 6.54M | n/a | n/a | n/a | 38.29K | 189.77K | 265.65K | 377.81K | 4.35M | n/a | 1.73M | n/a | n/a | n/a | 5.03M | 8.09M |
Total Liabilities | 2.9M | 9.31M | 2.28M | 3.5M | 2.71M | 3.53M | 5.79M | 3.79M | 5.83M | 4.35M | 3.77M | 1.73M | 1.85M | 2.53M | 2.2M | 6.56M | 8.88M |
Total Debt | n/a | 38.29K | 152.48K | 227.25K | 339.41K | 450.57K | 594.69K | 663.29K | 768.23K | n/a | n/a | n/a | n/a | n/a | n/a | 2.13M | 2.11M |
Common Stock | 2.33K | 103.00 | 1.73K | 727.00 | 581.00 | 63.00 | 1.07K | 195.00 | 1.58K | 1.3K | 1.3K | 1.3K | 1.3K | 1.29K | 1.29K | 464.00 | 464.00 |
Retained Earnings | -75.29M | -63.2M | -57.26M | -54.93M | -49.74M | -46.42M | -42.33M | -37.03M | -32.69M | -27.87M | -22.74M | -18.45M | -13.78M | -10.31M | -7.51M | -5.18M | -7.95M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | 0.00 | 0.00 | -9.45K | -9.35K | -12.89K |
Shareholders Equity | 10.29M | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M | 4.44M | 2.09M | -236.79K | 3.24M | 8.24M | 12.43M | 17M | 20.4M | 23.16M | -5.04M | -7.85M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.41 | 9.41 | 9.41K | 9.41 | 9.41K | 9.41K | 9.45K | 9.35K | 12.89K |